| VOR Stock | | | USD 1.08 0.03 2.70% |
Vor Biopharma financial indicator trend analysis is much more than just breaking down Vor Biopharma prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vor Biopharma is a good investment. Please check the relationship between Vor Biopharma Accounts Payable and its Non Current Assets Total accounts. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Vor Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in persons.
To learn how to invest in Vor Stock, please use our
How to Invest in Vor Biopharma guide.
Accounts Payable vs Non Current Assets Total
Accounts Payable vs Non Current Assets Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Vor Biopharma Accounts Payable account and
Non Current Assets Total. At this time, the significance of the direction appears to have strong relationship.
The correlation between Vor Biopharma's Accounts Payable and Non Current Assets Total is 0.71. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of Vor Biopharma, assuming nothing else is changed. The correlation between historical values of Vor Biopharma's Accounts Payable and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Vor Biopharma are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Accounts Payable i.e., Vor Biopharma's Accounts Payable and Non Current Assets Total go up and down completely randomly.
Correlation Coefficient | 0.71 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Accounts Payable
An accounting item on the balance sheet that represents Vor Biopharma obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Vor Biopharma are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Most indicators from Vor Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vor Biopharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Vor Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in persons.
To learn how to invest in Vor Stock, please use our
How to Invest in Vor Biopharma guide.As of 03/02/2025,
Selling General Administrative is likely to grow to about 38.3
M, while
Issuance Of Capital Stock is likely to drop slightly above 103.9
M.
Vor Biopharma fundamental ratios Correlations
Click cells to compare fundamentals
Vor Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vor Biopharma fundamental ratios Accounts
Additional Tools for Vor Stock Analysis
When running Vor Biopharma's price analysis, check to
measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to
predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.